Immunovant (IMVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DG heads into Q1 earnings with rising sales, shrinking margins and a stock that has outpaced rivals by more than 35% in three ...

Learn more about Epsium Enterprise Limited's (EPSM) stock grades for Value and Growth and determine whether this Distributors stock meets your investment needs.

Dynex Capital (DX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MicroStrategyMSTR shares have appreciated 27.9% year to date (YTD), outperforming the Zacks Computer Software industry’s rise ...

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

Learn more about West Coast Community Bancorp's (WCCB) stock grades for Value, Momentum and Growth and determine whether this ...

The large-ticket retailer’s report can help gauge demand for big-ticket goods when consumer confidence is down ...

Now, cloud computing stocks including Amazon.com, Inc. AMZN and Alphabet Inc. GOOGL are buying GPUs to boost computing power ...

For the most recent quarter, Royal Bank was expected to post earnings of $2.28 per share, but it reported $2.55 per share ...

If these stocks aren't leading their industries in uncertain market conditions, they're typically paying a hefty dividend.

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or ...